L-Ornithine-L-Aspartate Injection

Free

L-Ornithine L-Aspartate (LOLA) injection is a sterile, clear solution of two amino acids used to treat liver disorders, primarily hepatic encephalopathy. It works by reducing toxic ammonia levels in the blood by stimulating the urea cycle.

Category: Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Description

L-Ornithine-L-Aspartate Injection

Healthy Inc is a specialized global supplier and exporter of high-potency hepatoprotective agents. We provide high-purity L-Ornithine-L-Aspartate Injection (5 g / 10 ml), sourced from WHO–GMP certified sterile injectable facilities. This “Liver Coma” specialist is a top export to hepatology institutes, liver transplant units, and government health ministries in Africa, LATAM, and Southeast Asia, serving as the gold standard for reversing Hepatic Encephalopathy and lowering toxic blood ammonia levels in severe liver disease.


Product Overview

This formulation contains L-Ornithine-L-Aspartate (LOLA), a stable salt of two natural amino acids: Ornithine and Aspartic Acid.

The “Ammonia Trap” Specialist:

  • Mechanism (Dual Detoxification): In liver failure, the liver cannot convert toxic Ammonia (a byproduct of protein digestion) into Urea. This ammonia travels to the brain, causing confusion and coma (Hepatic Encephalopathy).
    • Ornithine: Stimulates the Urea Cycle in the liver, converting ammonia into urea for excretion.
    • Aspartate: Stimulates Glutamine Synthesis in the liver and skeletal muscle, trapping ammonia in the form of glutamine.
  • Rapid Awakening: IV infusion of LOLA is clinically proven to improve mental status (Grade of Encephalopathy) within 24-48 hours by drastically reducing serum ammonia.
  • Liver Rejuvenation: It also improves energy metabolism in damaged liver cells by normalizing the NADH/NAD ratio.

Product Composition & Strength

We supply this product as a Sterile Hypertonic Solution in Glass Ampoules. (Must be diluted).

Active Ingredient Strength Concentration
L-Ornithine-L-Aspartate 5 g (5000 mg) 500 mg/ml (10 ml Ampoule)
Excipients Water for Injection

*Pack Sizes: Tray of 5 Ampoules or 10 Ampoules.


Technical & Logistics Specifications

Critical data for Pharmaceutical Importers and Distributors.

HS Code 3004.90.99 (Medicaments containing other active substances)
Dosage Form Concentrate for Infusion (Liquid Solution)
Packaging Amber Type I Glass Ampoule (Light Sensitive) with Color Break Ring
Storage Store below 25°C. Protect from Light. Do not freeze.
Certificates WHO-GMP, COPP, Free Sale Certificate

Manufacturing Authority

Marketed and Distributed by Healthy Inc from WHO-GMP & ISO 9001:2015 certified units.

  • Stereoisomer Purity: We use only the biologically active L-isomers. The D-isomers are metabolically inert and increase renal load. Our enzymatic synthesis ensures >99% L-Ornithine and L-Aspartate content.
  • Color Stability: Amino acid solutions can darken (Maillard reaction) if exposed to heat or oxygen. We use Nitrogen blanketing during filling to ensure the product remains clear and colorless throughout its shelf life.

Therapeutic Indications (Human Use)

Indicated for the treatment of hyperammonemia and liver dysfunction:

  • Hepatic Encephalopathy (HE): Treatment of latent and manifest HE (Coma/Pre-coma).
  • Cirrhosis of Liver: Acute or chronic liver failure leading to high ammonia levels.
  • Fatty Liver (NASH): Adjunct therapy to improve liver enzymes.
  • Alcoholic Hepatitis: Detoxification support.

Dosage & Administration

Recommended Dosage (Strictly as per Hepatologist):

  • Route: Intravenous (IV) Infusion ONLY. (Dilution Mandatory).
  • Standard Dose (Chronic): 5 g (1 ampoule) daily.
  • Severe Case (Coma/Pre-coma): Up to 20 g to 40 g (4-8 ampoules) daily.
  • Infusion Rate: Max 5 g per hour.
  • Dilution Protocol (CRITICAL):
    • Mix ampoule contents in at least 500 ml of Saline, Dextrose 5%, or Ringer’s Lactate.
    • Do not inject undiluted. (Hypertonic solution causes vein damage).

Safety Warnings (CRITICAL):

  • Renal Function: Contraindicated in severe renal failure (Creatinine > 3 mg/dl). The kidneys must be functional to excrete the urea produced.
  • Nausea/Vomiting: Caused by rapid infusion. If this occurs, slow down the infusion rate.
  • Fructose Intolerance: Caution in patients with rare hereditary fructose intolerance (due to metabolic pathways).

Global Export & Contract Manufacturing Services

Healthy Inc stands as a premier Pharmaceutical Exporter in India, dedicated to serving the needs of international Pharma Traders, Wholesalers, and Bulk Drug Distributors. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) services for Sterile Injectables, allowing brands to launch high-quality generic medicines under their own label. Whether you are looking for a reliable Hospital Tender Supplier for government procurement in Africa or a B2B Pharma Marketplace partner for Latin America, our logistics network ensures timely delivery. We actively support Pharmaceutical Drop Shipping models and bulk indenting, ensuring that every Generic Medicine Wholesaler receives WHO-GMP certified products at competitive rates.

Reviews

There are no reviews yet.

Be the first to review “L-Ornithine-L-Aspartate Injection”

Your email address will not be published. Required fields are marked *